Kendric Cromer, a 12-year-old kid from a suburb of Washington, has become the first person in the world to receive commercially licensed gene therapy for sickle cell disease.
According to the New York Times, Kendric’s successful therapy provides hope to around 20,000 people in the United States who suffer from sickle cell disease. However, it also emphasises the difficulties patients confront in obtaining novel sickle cell medications.
Unlock exclusive access to the latest news on India’s general elections, only on the HT App. Download Now! Download Now!